Ionis Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $1.65B | $2.39B | $397.7M |
| FY2021 | $1.84B | $2.61B | $869.2M |
| FY2022 | $1.96B | $2.53B | $276.5M |
| FY2023 | $2.60B | $2.99B | $399.3M |
| FY2024 | $2.42B | $3.00B | $242.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $1.65B | $2.39B | $397.7M |
| FY2021 | $1.84B | $2.61B | $869.2M |
| FY2022 | $1.96B | $2.53B | $276.5M |
| FY2023 | $2.60B | $2.99B | $399.3M |
| FY2024 | $2.42B | $3.00B | $242.1M |